Objective to study the continuous monitoring method determining leucine aminopeptidase (LAP) and its clinical application.
目的探讨应用连续监测法测定尿亮氨酸氨基肽酶(lap)及其临床应用价值。
Objective To establish kinetic assay method for alanine aminopeptidase(AAP)in serum, be applied to clinical diagnosis primarily.
目的建立血清丙氨酸氨基肽酶（AAP）连续监测法。
Objective To establish a kinetic monitoring assay for detecting glycylproline dipeptidyl aminopeptidase (GPDA). Methods Gly-pro-pNA.
目的建立甘氨酰脯氨酰二肽氨基肽酶（GPDA）自动化分析方法。
Objective To study the role of urine leucine aminopeptidase (LAP) for sifting early renal injury in diabetic and hypertension patients.
目的探讨尿亮氨酸氨基肽酶(LAP)筛查糖尿病和高血压病早期肾损害的临床价值。
Objective To compare clinical significance of alanine aminopeptidase(AAP) and leucme aminopeptidase(LAP) activity in serum for hepatobiliary disease.
目的探讨血清丙氨酸氨基肽酶（AAP）和亮氨酸氨基肽酶（LAP）在肝胆疾病诊断中的应用价值。
Objectives:To explore the change rule and clinical value of glycylproline dipeptidyl aminopeptidase(GPDA) in tissues of esophageal and cardiac cancers.
目的：探讨甘氨酰脯氨酸二肽氨基肽酶（GPDA）在食管贲门癌组织中的变化规律。
Objective To study the clinical value of glycylproline dipeptidyl aminopeptidase(GPDA) in diagnosis of early kidney injury in the elderly with acute stroke.
目的研究尿甘氨酰脯氨酸二肽氨基肽酶（GPDA）诊断老年急性脑卒中患者早期肾损害的临床应用价值。
Aminopeptidase, a collection of enzymes which can remove amino acid from the N-terminus of peptides one by one, is very important in protein hydrolysate production and debittering.
氨肽酶是一类从多肽链的氮末端顺序逐个水解氨基酸的酶，在蛋白水解液脱苦和蛋白质的深度水解中有重要作用。
The bitterness could be removed by the addition of aminopeptidase. The amount of free amino acids was increased by 28.8 % and the amount of hydrophobic amino acid was also in-creased obviously.
结果1%的大豆蛋白质溶液经胰蛋白酶水解，水解液呈苦味，添加氨肽酶可较好地脱苦，水解液中游离氨基酸的总量增加了28.8%，疏水氨基酸的量也明显增加。
The bitterness could be removed by the addition of aminopeptidase. The amount of free amino acids was increased by 28.8 % and the amount of hydrophobic amino acid was also in-creased obviously.
结果1%的大豆蛋白质溶液经胰蛋白酶水解，水解液呈苦味，添加氨肽酶可较好地脱苦，水解液中游离氨基酸的总量增加了28.8%，疏水氨基酸的量也明显增加。
应用推荐